Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery
- PMID: 28210470
- PMCID: PMC5304097
- DOI: 10.15171/jcvtr.2016.31
Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery
Abstract
Introduction: Inadequate adherence to medication and follow up visits were proposed correlated with cardiovascular mortality and complications. This study was planned to evaluate medication and follow up adherence and risk factor control in patients with coronary artery disease 5 years after coronary artery bypass grafting (CABG). Methods: In this retrospective cohort study, adult patients who underwent CABG in 2010 were enrolled. Conventional and probable risk factor control and adherence to medication and follow up visits were assessed. Results: 196 patients were recruited to the study. Uncontrolled blood pressure, blood glucose and low-density lipoprotein (LDL)were reported in 48%, 61% and 32% of patients, respectively. More than 63% of former smokers restarted smoking during 6-12 months after bypass. Poor medication adherence was present in 10.7% in the study population. The last follow up visit time for 30% of patients was later than 12 months after CABG. Conclusion: Poor risk factors control and adherence to follow up visits was common among patients undergoing CABG.
Keywords: Coronary Artery Bypass Graft; Medication Adherence; Risk Factor Control; Smoking.
References
-
- Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T. et al. Long-term graft patency (3 years) after coronary artery surgery Effects of aspirin: results of a VA Cooperative study. Circulation. 1994;89:1138–43. - PubMed
-
- Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE. et al. Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98. - PubMed
-
- Chobanian AV, Bakris G, Black H, Cushman W, Green L, Izzo J Jr. et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC. Hypertension. 2003;7:2560–72. - PubMed
-
- Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA. et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58:2432–46. - PubMed
-
- Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources